Literature DB >> 15209521

Tyrphostins are inhibitors of guanylyl and adenylyl cyclases.

Mahaboobi Jaleel1, Avinash R Shenoy, Sandhya S Visweswariah.   

Abstract

Guanylyl cyclase C (GC-C), the receptor for guanylin, uroguanylin, and the heat-stable enterotoxin, regulates fluid balance in the intestine and extraintestinal tissues. The receptor has an extracellular domain, a single transmembrane spanning domain, and an intracellular domain that harbors a region homologous to protein kinases, followed by the C-terminal guanylyl cyclase domain. Adenine nucleotides can regulate the guanylyl cyclase activity of GC-C by binding to the intracellular kinase homology domain (KHD). In this study, we have tested the effect of several protein kinase inhibitors on GC-C activity and find that the tyrphostins, known to be tyrosine kinase inhibitors, could inhibit GC-C activity in vitro. Tyrphostin A25 (AG82) was the most potent inhibitor with an IC(50) of approximately 15 microM. The mechanism of inhibition was found to be noncompetitive with respect to both the substrate MnGTP and the metal cofactor. Interestingly, the activity of the catalytic domain of GC-C (lacking the KHD) expressed in insect cells was also inhibited by tyrphostin A25 with an IC(50) of approximately 5 microM. As with the full-length receptor, inhibition was found to be noncompetitive with respect to MnGTP. Inhibition was reversible, ruling out a covalent modification of the receptor. Structurally similar proteins such as the soluble guanylyl cyclase and the adenylyl cyclases were also inhibited by tyrphostin A25. Evaluation of a number of tyrphostins allowed us to identify the requirement of two vicinal hydroxyl groups in the tyrphostin for effective inhibition of cyclase activity. Therefore, our studies are the first to report that nucleotide cyclases are inhibited by tyrphostins and suggest that novel inhibitors based on the tyrphostin scaffold can be developed, which could aid in a greater understanding of nucleotide cyclase structure and function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15209521     DOI: 10.1021/bi036234n

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  16 in total

Review 1.  Molecular details of cAMP generation in mammalian cells: a tale of two systems.

Authors:  Margarita Kamenetsky; Sabine Middelhaufe; Erin M Bank; Lonny R Levin; Jochen Buck; Clemens Steegborn
Journal:  J Mol Biol       Date:  2006-07-28       Impact factor: 5.469

2.  A novel mechanism for adenylyl cyclase inhibition from the crystal structure of its complex with catechol estrogen.

Authors:  Clemens Steegborn; Tatiana N Litvin; Kenneth C Hess; Austin B Capper; Ronald Taussig; Jochen Buck; Lonny R Levin; Hao Wu
Journal:  J Biol Chem       Date:  2005-07-07       Impact factor: 5.157

Review 3.  Inhibitors of membranous adenylyl cyclases.

Authors:  Roland Seifert; Gerald H Lushington; Tung-Chung Mou; Andreas Gille; Stephen R Sprang
Journal:  Trends Pharmacol Sci       Date:  2011-11-17       Impact factor: 14.819

4.  Inhibition of TNFα-induced iNOS expression in HSV-tk transduced 9L glioblastoma cell lines by Marasmius oreades substances through NF-κB- and MAPK-dependent mechanisms.

Authors:  Nili Ruimi; Roumyana D Petrova; Riad Agbaria; Sherbel Sussan; Solomon P Wasser; Abraham Z Reznick; Jamal Mahajna
Journal:  Mol Biol Rep       Date:  2010-03-12       Impact factor: 2.316

5.  Characterization of phylogenetically distant members of the adenylate cyclase family from mycobacteria: Rv1647 from Mycobacterium tuberculosis and its orthologue ML1399 from M. leprae.

Authors:  Avinash R Shenoy; Nandini P Sreenath; Mohana Mahalingam; Sandhya S Visweswariah
Journal:  Biochem J       Date:  2005-04-15       Impact factor: 3.857

6.  Receptor guanylyl cyclase C (GC-C): regulation and signal transduction.

Authors:  Nirmalya Basu; Najla Arshad; Sandhya S Visweswariah
Journal:  Mol Cell Biochem       Date:  2009-12-04       Impact factor: 3.396

Review 7.  Inhibition of the insulin-like growth factor-1 receptor (IGF1R) tyrosine kinase as a novel cancer therapy approach.

Authors:  Rongshi Li; Alan Pourpak; Stephan W Morris
Journal:  J Med Chem       Date:  2009-08-27       Impact factor: 7.446

8.  Tumoral and macrophage uPAR and MMP-9 contribute to the invasiveness of B16 murine melanoma cells.

Authors:  Chiara Marconi; Francesca Bianchini; Antonella Mannini; Gabriele Mugnai; Salvatore Ruggieri; Lido Calorini
Journal:  Clin Exp Metastasis       Date:  2007-12-11       Impact factor: 5.150

9.  Interactions of methoxyacetic acid with androgen receptor.

Authors:  Gargi Bagchi; Christopher H Hurst; David J Waxman
Journal:  Toxicol Appl Pharmacol       Date:  2008-04-07       Impact factor: 4.219

10.  Structure-based development of novel adenylyl cyclase inhibitors.

Authors:  Christine Schlicker; Annika Rauch; Ken C Hess; Barbara Kachholz; Lonny R Levin; Jochen Buck; Clemens Steegborn
Journal:  J Med Chem       Date:  2008-07-17       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.